Loading…
Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats
Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total...
Saved in:
Published in: | Nutrients 2021-06, Vol.13 (6) |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 6 |
container_start_page | |
container_title | Nutrients |
container_volume | 13 |
creator | Yang, Lingshuang Xie, Xinqiang Li, Ying Wu, Lei Fan, Congcong Liang, Tingting Xi, Yu Yang, Shuanghong Li, Haixin Zhang, Jumei Ding, Yu Xue, Liang Chen, Moutong Wang, Juan Wu, Qingping |
description | Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), liver TC and TG and increased fecal TC, TG and total bile acid (TBA) levels. Additionally, both strains also reduced glutamic-pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST) and levels of tissue inflammation levels to improve the lipid profile, and they reduced fat accumulation partially by alleviating inflammatory responses. Furthermore, both strains regulated the expression of the CYP8B1, CYP7A1, SREBP-1, SCD1 and LDL-R gene to promote cholesterol metabolism and reduce TG accumulation. Interventions with both strains also altered the gut microbiota, and decreasing the abundance of Veillonellaceae, Erysipelotrichaceae and Prevotella. Furthermore, fecal acetic acid and propionic acid were increased by this intervention. Overall, the results suggested that E. faecium strain 132 and L. paracasei strain 201 can alleviate hypercholesterolemia in rats and might be applied as a new type of hypercholesterolemia agent in functional foods. |
doi_str_mv | 10.3390/nu13061982 |
format | article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A765644471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A765644471</galeid><sourcerecordid>A765644471</sourcerecordid><originalsourceid>FETCH-LOGICAL-g671-3d4cf8bd7dd5cd8cdea12592c8b6755594b79f27d2504581567bcb1bb8e5ffcd3</originalsourceid><addsrcrecordid>eNptjlFLwzAQx4MoOOZe_AQBn7s1aZO0j2NMV6gIuveRXJIt0iajaRU_jN_VDoXtwbuH_3H3u7s_QvcknWdZmS78QLKUk7KgV2hCU0ETzvPs-qK-RbMY39NTiFTwbIK-1x-yGWTvgsfB4v5g8OoQGhN704UmqcOn6Zzf42cDB-ldbE9UtfanMQSAIWIrDbihXVT4re-k85hkFEuvcVVL6IOS4Jpm5I6ykyCjcWeSpgSPsvk6mg7Ob03rJH6VfbxDN1Y20cz-dIq2j-vtapPUL0_Valkney5IkukcbKG00JqBLkAbSSgrKRSKC8ZYmStRWio0ZWnOCsK4UKCIUoVh1oLOpujh9-xeNmbnvA2jPWhdhN1ScMbzPBdkpOb_UGPq0S8Eb6wb-xcLPwmAfAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Yang, Lingshuang ; Xie, Xinqiang ; Li, Ying ; Wu, Lei ; Fan, Congcong ; Liang, Tingting ; Xi, Yu ; Yang, Shuanghong ; Li, Haixin ; Zhang, Jumei ; Ding, Yu ; Xue, Liang ; Chen, Moutong ; Wang, Juan ; Wu, Qingping</creator><creatorcontrib>Yang, Lingshuang ; Xie, Xinqiang ; Li, Ying ; Wu, Lei ; Fan, Congcong ; Liang, Tingting ; Xi, Yu ; Yang, Shuanghong ; Li, Haixin ; Zhang, Jumei ; Ding, Yu ; Xue, Liang ; Chen, Moutong ; Wang, Juan ; Wu, Qingping</creatorcontrib><description>Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), liver TC and TG and increased fecal TC, TG and total bile acid (TBA) levels. Additionally, both strains also reduced glutamic-pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST) and levels of tissue inflammation levels to improve the lipid profile, and they reduced fat accumulation partially by alleviating inflammatory responses. Furthermore, both strains regulated the expression of the CYP8B1, CYP7A1, SREBP-1, SCD1 and LDL-R gene to promote cholesterol metabolism and reduce TG accumulation. Interventions with both strains also altered the gut microbiota, and decreasing the abundance of Veillonellaceae, Erysipelotrichaceae and Prevotella. Furthermore, fecal acetic acid and propionic acid were increased by this intervention. Overall, the results suggested that E. faecium strain 132 and L. paracasei strain 201 can alleviate hypercholesterolemia in rats and might be applied as a new type of hypercholesterolemia agent in functional foods.</description><identifier>ISSN: 2072-6643</identifier><identifier>EISSN: 2072-6643</identifier><identifier>DOI: 10.3390/nu13061982</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Acetic acid ; Anticholesteremic agents ; Bile acids ; Cholesterol ; Hypercholesterolemia ; Inflammation ; Liver ; Low density lipoproteins ; Microbiota (Symbiotic organisms) ; Triglycerides</subject><ispartof>Nutrients, 2021-06, Vol.13 (6)</ispartof><rights>COPYRIGHT 2021 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Yang, Lingshuang</creatorcontrib><creatorcontrib>Xie, Xinqiang</creatorcontrib><creatorcontrib>Li, Ying</creatorcontrib><creatorcontrib>Wu, Lei</creatorcontrib><creatorcontrib>Fan, Congcong</creatorcontrib><creatorcontrib>Liang, Tingting</creatorcontrib><creatorcontrib>Xi, Yu</creatorcontrib><creatorcontrib>Yang, Shuanghong</creatorcontrib><creatorcontrib>Li, Haixin</creatorcontrib><creatorcontrib>Zhang, Jumei</creatorcontrib><creatorcontrib>Ding, Yu</creatorcontrib><creatorcontrib>Xue, Liang</creatorcontrib><creatorcontrib>Chen, Moutong</creatorcontrib><creatorcontrib>Wang, Juan</creatorcontrib><creatorcontrib>Wu, Qingping</creatorcontrib><title>Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats</title><title>Nutrients</title><description>Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), liver TC and TG and increased fecal TC, TG and total bile acid (TBA) levels. Additionally, both strains also reduced glutamic-pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST) and levels of tissue inflammation levels to improve the lipid profile, and they reduced fat accumulation partially by alleviating inflammatory responses. Furthermore, both strains regulated the expression of the CYP8B1, CYP7A1, SREBP-1, SCD1 and LDL-R gene to promote cholesterol metabolism and reduce TG accumulation. Interventions with both strains also altered the gut microbiota, and decreasing the abundance of Veillonellaceae, Erysipelotrichaceae and Prevotella. Furthermore, fecal acetic acid and propionic acid were increased by this intervention. Overall, the results suggested that E. faecium strain 132 and L. paracasei strain 201 can alleviate hypercholesterolemia in rats and might be applied as a new type of hypercholesterolemia agent in functional foods.</description><subject>Acetic acid</subject><subject>Anticholesteremic agents</subject><subject>Bile acids</subject><subject>Cholesterol</subject><subject>Hypercholesterolemia</subject><subject>Inflammation</subject><subject>Liver</subject><subject>Low density lipoproteins</subject><subject>Microbiota (Symbiotic organisms)</subject><subject>Triglycerides</subject><issn>2072-6643</issn><issn>2072-6643</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjlFLwzAQx4MoOOZe_AQBn7s1aZO0j2NMV6gIuveRXJIt0iajaRU_jN_VDoXtwbuH_3H3u7s_QvcknWdZmS78QLKUk7KgV2hCU0ETzvPs-qK-RbMY39NTiFTwbIK-1x-yGWTvgsfB4v5g8OoQGhN704UmqcOn6Zzf42cDB-ldbE9UtfanMQSAIWIrDbihXVT4re-k85hkFEuvcVVL6IOS4Jpm5I6ykyCjcWeSpgSPsvk6mg7Ob03rJH6VfbxDN1Y20cz-dIq2j-vtapPUL0_Valkney5IkukcbKG00JqBLkAbSSgrKRSKC8ZYmStRWio0ZWnOCsK4UKCIUoVh1oLOpujh9-xeNmbnvA2jPWhdhN1ScMbzPBdkpOb_UGPq0S8Eb6wb-xcLPwmAfAg</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Yang, Lingshuang</creator><creator>Xie, Xinqiang</creator><creator>Li, Ying</creator><creator>Wu, Lei</creator><creator>Fan, Congcong</creator><creator>Liang, Tingting</creator><creator>Xi, Yu</creator><creator>Yang, Shuanghong</creator><creator>Li, Haixin</creator><creator>Zhang, Jumei</creator><creator>Ding, Yu</creator><creator>Xue, Liang</creator><creator>Chen, Moutong</creator><creator>Wang, Juan</creator><creator>Wu, Qingping</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20210601</creationdate><title>Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats</title><author>Yang, Lingshuang ; Xie, Xinqiang ; Li, Ying ; Wu, Lei ; Fan, Congcong ; Liang, Tingting ; Xi, Yu ; Yang, Shuanghong ; Li, Haixin ; Zhang, Jumei ; Ding, Yu ; Xue, Liang ; Chen, Moutong ; Wang, Juan ; Wu, Qingping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g671-3d4cf8bd7dd5cd8cdea12592c8b6755594b79f27d2504581567bcb1bb8e5ffcd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acetic acid</topic><topic>Anticholesteremic agents</topic><topic>Bile acids</topic><topic>Cholesterol</topic><topic>Hypercholesterolemia</topic><topic>Inflammation</topic><topic>Liver</topic><topic>Low density lipoproteins</topic><topic>Microbiota (Symbiotic organisms)</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Lingshuang</creatorcontrib><creatorcontrib>Xie, Xinqiang</creatorcontrib><creatorcontrib>Li, Ying</creatorcontrib><creatorcontrib>Wu, Lei</creatorcontrib><creatorcontrib>Fan, Congcong</creatorcontrib><creatorcontrib>Liang, Tingting</creatorcontrib><creatorcontrib>Xi, Yu</creatorcontrib><creatorcontrib>Yang, Shuanghong</creatorcontrib><creatorcontrib>Li, Haixin</creatorcontrib><creatorcontrib>Zhang, Jumei</creatorcontrib><creatorcontrib>Ding, Yu</creatorcontrib><creatorcontrib>Xue, Liang</creatorcontrib><creatorcontrib>Chen, Moutong</creatorcontrib><creatorcontrib>Wang, Juan</creatorcontrib><creatorcontrib>Wu, Qingping</creatorcontrib><jtitle>Nutrients</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Lingshuang</au><au>Xie, Xinqiang</au><au>Li, Ying</au><au>Wu, Lei</au><au>Fan, Congcong</au><au>Liang, Tingting</au><au>Xi, Yu</au><au>Yang, Shuanghong</au><au>Li, Haixin</au><au>Zhang, Jumei</au><au>Ding, Yu</au><au>Xue, Liang</au><au>Chen, Moutong</au><au>Wang, Juan</au><au>Wu, Qingping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats</atitle><jtitle>Nutrients</jtitle><date>2021-06-01</date><risdate>2021</risdate><volume>13</volume><issue>6</issue><issn>2072-6643</issn><eissn>2072-6643</eissn><abstract>Hypercholesterolemia can cause many diseases, but it can effectively regulated by Lactobacillus. This study aimed to evaluate the cholesterol-lowering mechanism of Enterococcus faecium strain 132 and Lactobacillusparacasei strain 201. These results showed that both the strains decreased serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), liver TC and TG and increased fecal TC, TG and total bile acid (TBA) levels. Additionally, both strains also reduced glutamic-pyruvic transaminase (ALT), glutamic oxaloacetic transaminase (AST) and levels of tissue inflammation levels to improve the lipid profile, and they reduced fat accumulation partially by alleviating inflammatory responses. Furthermore, both strains regulated the expression of the CYP8B1, CYP7A1, SREBP-1, SCD1 and LDL-R gene to promote cholesterol metabolism and reduce TG accumulation. Interventions with both strains also altered the gut microbiota, and decreasing the abundance of Veillonellaceae, Erysipelotrichaceae and Prevotella. Furthermore, fecal acetic acid and propionic acid were increased by this intervention. Overall, the results suggested that E. faecium strain 132 and L. paracasei strain 201 can alleviate hypercholesterolemia in rats and might be applied as a new type of hypercholesterolemia agent in functional foods.</abstract><pub>MDPI AG</pub><doi>10.3390/nu13061982</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6643 |
ispartof | Nutrients, 2021-06, Vol.13 (6) |
issn | 2072-6643 2072-6643 |
language | eng |
recordid | cdi_gale_infotracmisc_A765644471 |
source | Publicly Available Content Database; PubMed Central |
subjects | Acetic acid Anticholesteremic agents Bile acids Cholesterol Hypercholesterolemia Inflammation Liver Low density lipoproteins Microbiota (Symbiotic organisms) Triglycerides |
title | Evaluation of the Cholesterol-Lowering Mechanism of IEnterococcus faecium/I Strain 132 and ILactobacillus paracasei/I Strain 201 in Hypercholesterolemia Rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A28%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20Cholesterol-Lowering%20Mechanism%20of%20IEnterococcus%20faecium/I%20Strain%20132%20and%20ILactobacillus%20paracasei/I%20Strain%20201%20in%20Hypercholesterolemia%20Rats&rft.jtitle=Nutrients&rft.au=Yang,%20Lingshuang&rft.date=2021-06-01&rft.volume=13&rft.issue=6&rft.issn=2072-6643&rft.eissn=2072-6643&rft_id=info:doi/10.3390/nu13061982&rft_dat=%3Cgale%3EA765644471%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g671-3d4cf8bd7dd5cd8cdea12592c8b6755594b79f27d2504581567bcb1bb8e5ffcd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A765644471&rfr_iscdi=true |